Full text is available at the source.
Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice
Inulin and metformin reduce polycystic ovary symptoms in mice by lowering inflammation and changing gut bacteria
AI simplified
Abstract
Body weight and testosterone levels were significantly decreased, while estradiol levels were increased in the inulin and metformin groups.
- Inulin and metformin both improved ovarian morphology in a mouse model of polycystic ovary syndrome (PCOS).
- Inflammatory markers such as TNF-α, IL-6, and IL-17A were reduced in the inulin and metformin groups.
- The anti-inflammatory effects were associated with an increase in IL-10 levels in the ovaries of the inulin and metformin groups.
- Gut microbiota analysis revealed an increase in Bifidobacterium and a decrease in Proteobacteria, Helicobacter, and Parasutterella in the inulin group.
- Helicobacter levels were also reduced in the metformin group, indicating changes in gut microbiota composition.
AI simplified